The Procter & Gamble Company (PG) research: valuation against peers, fundamentals over time, risk and news coverage

PG

The Procter & Gamble Company
USD
147.82
-0.40% today
Market cap
—
P/E trailing
—
P/E forward
—
EV/EBITDA
—
Op margin
—
Rev growth
—
Div yield
—
Beta
—
52-week range138.04 – 167.201 report(s) in our archive
Price navigator — PG

No data in this window.

    INDY NEWS coverage of PG1

    Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.

    Full archive search for PG

    Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.

    Guidance reliability · PGmethodology·all companies

    Only 1 resolved forecast on record — below the 6-period threshold, so no verdict is published.

    n = 1 resolved forecast · FY 2025 to FY 2025 · 2 still outstanding

    Insufficient sample — no verdict published. PG has 1 resolved forecast on record, below the 6 needed before we will characterise a management team’s forecasting. The record below is published in full; the company is excluded from every ranking on this site until it clears the threshold.

    Pattern
    Not enough resolved periods
    1 resolved
    Avg. signed deviation
    +0.1%
    outside its own range
    Avg. vs midpoint
    +0.9%
    where in the range it lands
    Avg. range width
    1.5%
    room it leaves itself
    Above guidance1

    Next report expected 23 Oct 2026 (Q1 FY2027) — Estimated from the issuer's own filing history: FY2026Q1 results were released on 2025-10-24. source

    The record — 5 forecasts, 3 scoredevery figure sourced
    Every forecast PG management issued in its own earnings releases, with the outcome the company later reported and a link to both source documents.
    PeriodMeasureGuidedIssuedReportedLandedDeviationVerdictSources
    FY 2027EPS (adj.)$6.89–$7.112026-07-29———PENDINGguidance
    “This outlook equates to a range of $6.89 to $7.11 per share, with a mid-point estimate of $7.00, or an increase of one and a half percent.”
    FY 2026revisedEPS (adj.)$6.83–$7.092026-04-24———PENDINGguidance
    “P&G also maintained its fiscal 2026 core earnings per share growth to be in the range of in-line to up four percent versus fiscal 2025 core EPS of $6.83. This outlook equates to a range of $6.83 to $7.09 per share.”
    FY 2026revisedEPS (adj.)$6.83–$7.092026-01-22———PENDINGguidance
    “This outlook equates to a range of $6.83 to $7.09 per share, with a mid-point estimate of $6.96, or an increase of two percent.”
    FY 2026EPS (adj.)$6.83–$7.092025-10-24———PENDINGguidance
    “This outlook equates to a range of $6.83 to $7.09 per share, with a mid-point estimate of $6.96, or an increase of 2%.”
    FY 2025EPS (adj.)$6.72–$6.822025-04-24$6.83+0.1%ABOVEguidance · result
    “Core EPS Growth: $6.72 to $6.82”

    Every figure above is read from the company’s own filings. “Guidance” links to the 8-K exhibit that issued the forecast; “result” links to the exhibit in which the company reported the outcome. Nothing here is an analyst estimate. How this is measured.

    Coverage universe: S&P 100. This is a factual record of what a company forecast and what it then reported. It is not investment advice, and it is not a view on the company’s prospects — we publish the measurement and draw no conclusion from it.